✦ LIBER ✦

Adjuvant hormonetherapy for slow proliferating node-negative breast cancer patients. Results of the phase III trial of NCl-Bari

✍ Scribed by A. Paradiso; M. De Lena; M. Sambiasi; A. Mangia; M. Brandi; F. Schittulli

Book ID: 114315654
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 221 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80129-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant polychemotherapy vs control for

Adjuvant polychemotherapy vs control for node-negative, rapidly proliferating breast cancer: Combined analysis of two phase III trials

✍ A. Paradiso; M. De Lena; F. Schittulli; A. Mangia; O. Nanni; A. Volpi; D. Casade 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Phase III randomized multicenter study o

Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis

✍ Dino Amadori; Oriana Nanni; Annalisa Volpi; Donata Casadei Giunchi; Maurizio Mar 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 217 KB

Randomized phase III trial of adjuvant e

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

✍ Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Roc 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 485 KB

Definitive Results of a Phase III Adjuva

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

✍ Swain, S. M.; Tang, G.; Geyer, C. E.; Rastogi, P.; Atkins, J. N.; Donnellan, P. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 777 KB

The Role of Tamoxifen in Treatment of Hi

The Role of Tamoxifen in Treatment of High-Risk, Node-Negative Breast Cancer Patients: Results of a Phase III Intergroup Trial (SWOG 8897, INT-102)1

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

Technical outcomes of sentinel-lymph-nod

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

✍ David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; T 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 128 KB